ExactAntigen

MAP2K6 antibody review
MAP2K6 antibodies
This is a review about MAP2K6 antibodies, based on 6 published articles using MAP2K6 antibodies in western blot, immunohistochemistry, immunoprecipitation, immunocytochemistry, and other immunological technologies. It is aimed to help ExactAntigen visitors find the most suited MAP2K6 antibody. Information in this review (with links to publications) can be searched freely.
CELL SIGNALING TECHNOLOGY    search Cell Signaling Technology MAP2K6 products
includes other brands or spellings
wb    Cell Signaling anti-phospho-MKK6 antibody was used in western blot to study inhibition of MAPK and NFkappaB signaling pathways through preventing activation of the family of MAPK kinases (MAPKK).
wb    Cell Signaling Technology polyclonal antibodies against phosphorylated and total MKK3/MKK6 were used in western blot to investigate the significance of the specific activation of the p38 MAP kinase pathway for TGF-beta1- and Smad7-induced apoptosis in human prostate cancer cells.
wb    New England Biolabs anti-phosphorylated MKK6 antibody were used in western blot to study the effect of serine protease plasmin on expression of MCP-1 and CD40 in human primary monocytes.
wb    Cell Signaling Technology anti-phospho-MAPK kinase 6 antibody was used in western blot to study the expression of hypertonicity-induced aquaporin-1 (AQP1) which is mediated by the activation of MAPK pathways and hypertonicity-responsive element in the AQP1 gene.
wb    Cell Signaling anti-phospho-MKK3/6 antibody was used in western blot to study the association between TRAF4 and MEKK4.
SANTA CRUZ BIOTECHNOLOGY    search Santa Cruz Biotechnology MAP2K6 products
includes other brands or spellings
wb    Santa Cruz Biotechnology anti-MKK6 antibody was used in Western blot to study the biological function of Rac-MKK3/6-p38 pathway.


Articles Reviewed
1. Ladislav Burysek et al. The serine protease plasmin triggers expression of MCP-1 and CD40 in human primary monocytes via activation of p38 MAPK and janus kinase (JAK)/STAT signaling pathways. 2002
2. Sofia Edlund et al. Transforming growth factor-beta1 (TGF-beta)-induced apoptosis of prostate cancer cells involves Smad7-dependent activation of p38 by TGF-beta-activated kinase 1 and mitogen-activated protein kinase kinase 3. 2003
3. Fuminori Umenishi et al. Hypertonicity-induced aquaporin-1 (AQP1) expression is mediated by the activation of MAPK pathways and hypertonicity-responsive element in the AQP1 gene. 2003
4. Ilchung Shin et al. H-Ras-specific activation of Rac-MKK3/6-p38 pathway: its critical role in invasion and migration of breast epithelial cells. 2005
5. Amy N Abell et al. MEKK4 is an effector of the embryonic TRAF4 for JNK activation. 2005
6. Sohini Mukherjee et al. Yersinia YopJ acetylates and inhibits kinase activation by blocking phosphorylation. 2006


2008©ExactAntigen home | browse | about